4TVJ
HUMAN ARTD2 (PARP2) - CATALYTIC DOMAIN IN COMPLEX WITH OLAPARIB
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I04 |
Synchrotron site | Diamond |
Beamline | I04 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2011-07-27 |
Detector | ADSC QUANTUM 315 |
Wavelength(s) | 0.99190 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 58.083, 134.123, 58.348 |
Unit cell angles | 90.00, 117.96, 90.00 |
Refinement procedure
Resolution | 29.280 - 2.100 |
R-factor | 0.18984 |
Rwork | 0.188 |
R-free | 0.23103 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3kcz |
RMSD bond length | 0.017 |
RMSD bond angle | 1.530 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | REFMAC (5.5.0102) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 30.000 | 2.150 |
High resolution limit [Å] | 2.100 | 2.100 |
Rmerge | 0.109 | 0.669 |
Number of reflections | 45851 | |
<I/σ(I)> | 14.6 | 3.1 |
Completeness [%] | 99.5 | 98.4 |
Redundancy | 7.5 | 7.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 277 | 25% PEG3350, 0.1M Tris |